Baltimore-Washington Financial Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,239	Closed	-$207K	–	71
2016 Q4	$207K	Sell	4,239 -30,087	-88%	-$1.39M	0.06%	73
2016 Q3	$1.64M	Sell	34,326 -34,974	-50%	-$1.73M	0.47%	61
2016 Q2	$3.72M	Buy	69,300 +515	+0.7%	+$24.3K	1.11%	46
2016 Q1	$3.08M	Sell	68,785 -251	-0.4%	-$10.2K	0.93%	47
2015 Q4	$2.63M	Buy	69,036 +7,905	+13%	+$302K	0.82%	58
2015 Q3	$1.95M	Buy	61,131 +7,291	+14%	+$254K	0.62%	68
2015 Q2	$1.78M	Buy	53,840 +9,950	+23%	+$355K	0.53%	69
2015 Q1	$1.81M	Buy	43,890 +3,600	+9%	+$146K	0.53%	69
2014 Q4	$1.64M	Buy	40,290 +14,535	+56%	+$568K	0.49%	68
2014 Q3	$944K	Buy	25,755 +1,365	+6%	+$59K	0.3%	74
2014 Q2	$1.13M	Buy	24,390 +1,525	+7%	+$67.8K	0.35%	76
2014 Q1	$940K	Sell	22,865 -14,685	-39%	-$546K	0.32%	74
2013 Q4	$1.43M	Buy	37,550 +2,180	+6%	+$67.3K	0.48%	69
2013 Q3	$845K	Buy	35,370 +19,130	+118%	+$429K	0.33%	72
2013 Q2	$276K	Buy	+16,240	New	+$234K	0.12%	84